|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0542 - 0.0599|
|52 Week Range||0.0005 - 0.1580|
|Beta (3Y Monthly)||71.19|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Vystar Corporation, (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification products, announced that FirstFire Global Opportunities Fund, LLC (FirstFire), an institutional investor who previously provided funding to Vystar, has invested $200,000 in Vystar at $0.15 per restricted common share, a 250 percent premium to yesterday’s market close. The stock purchase has no rights for conversion or warrants associated with it.
Vystar Corporation, (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification products, announced that it has made payment of $142,000 including principal of $103,000, and interest of 12% and fees to retire the convertible promissory note held by PowerUp Lending Group, Ltd. (PowerUp) dated October 23, 2018. Since December of 2018, Vystar has paid off approximately $380,000 to PowerUp and has no additional notes with them.
WORCESTER, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Vystar Corp. (OTC Market: VYST) has been granted European, EP Patent No. 2238183 entitled “Natural Rubber Latex Having Reduced Allergenicity and Method of Making Same.” Vystar now holds 13 foreign and 4 U.S. patents related to its latex deproteinization process for the production of Vytex®, a natural rubber latex (NRL) that is virtually free of allergen-causing latex proteins, thereby reducing risk of developing or experiencing allergic reactions to latex from direct contact. “This patent extends important intellectual property (IP) protection for Vystar in the production and distribution of Vytex to Europe using the Vytex formula to meet the growing demand for low protein NRL for products including balloons, examination and surgical gloves, condoms, breather bags, latex tubing, probe covers, catheters, threads, foams, cold seal and pressure sensitive adhesives,” stated Steve Rotman, CEO of Vystar.
Destroys on first pass more than 99.97% of harmful airborne viruses and bacteria. Inactivates pathogens that cause measles, the common cold, MRSA (staph), whooping cough, TB, pneumonia and other antibiotic-resistant and viral infections.
Features longer-lasting, more effective UV light for more efficient inactivation of viruses and bacteriaRxAir available for medical, business and residentialRxAir now available.
Sustainably sourced Vytex latex for ultra-long life, yet completely biodegradable. WORCESTER, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Vystar® Corporation (VYST) today began the New England soft launch of Vytex® Cloud Bed-in-a-Box Collection of 100% all natural latex mattresses in three levels of support. The Bed-in-a-Box concept is a hit with consumers - transforming the $30 billion dollar a year mattress industry. Industry Bed-in-a-Box sales grew by 60% in 2017. In a society that is now comfortable with online sales and enjoys the convenience of to your door delivery, Bed-in-a-Box sales now account for nearly 30% of all mattress sales.
Vystar Corporation, (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification products, announced that the board has authorized a stock buyback plan of up to 250 million shares, which represents approximately half of the outstanding shares, and has paid off a $105,000 convertible note in cash to limit dilution. Vystar paid off the remaining outstanding Peak One convertible note, due January 22, 2019 for $105,000 in cash on December 19th, 2019.